FDA Approved: ETHOSUXIMIDE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ethosuximide by Bionpharma Inc., marking a supplemental regulatory action under ANDA 040430. The drug is used to tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Seizures

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

SUPPL AP for ETHOSUXIMIDE (ETHOSUXIMIDE)